Mpathy Medical is touting the results of a small study of its Omnisure sling for treating female stress urinary incontinence.
The Glasgow, Scotland based company, which has its U.S. headquarters in Raynham, Mass., said the 61-patient trial showed a 92.4 percent cure rate, defined as patients who were reported as “dry” after implantation.
Pubovaginal slings are implanted under the neck of the bladder (the proximal or mid-urethra) to physically support them and relieve the stress that causes incontinence. Mpathy claims the Omnisure device can be implanted using the narrowest needle possible.
A third financing round, completed earlier this year, brought the total amount invested in the company in the past year to more than $5.4 million.